View by:  topics - messages Show:  titles only - summary Start a new discussion My starred discussions My profile

Positive Phase 3 results of an erectile dysfunction (ED) drug  VIVUS Inc. (VVUS) reported positive results for Avanafil, their erectile dysfunction (ED) drug. New BioMedicine had issued a report with positive coverage of this event on May 5, 2009. Stock up 111.7% from the date of our coverage till after the news announcement. To know about the disease, the drug, the market potential, the... more » tanu - Nov 19, 7:33 am - 1 new of 1 message     3SBio Inc.

Positive data from an early stage trial of a sarcoma drug.........  Threshold Pharmaceuticals, Inc. (THLD) reported positive results for TH-302, their sarcoma drug. New BioMedicine issued positive coverage of this event on August 18, 2009. The stock is up 115% from the date of our coverage. To read our report, which covers the disease, the drug, the market potential, the competition, etc., access it FREE at:... more » babu - Nov 12, 7:24 am - 1 new of 1 message     3SBio Inc.

FDA Decision on approval of a small cap company's drug for Anemia on June 29th  The upcoming FDA Decision date on JUNE 29th (TODAY) for this small cap company's drug for Anemia patients will affect SSRX directly. To read about HOW it will affect SSRX and about our opinion on whether the drug will be approved or not, along with details of the company, the drug, the disease, the competitors, the market and the sales potential... more » debapriyadutta - Jun 29, 8:29 am - 1 new of 1 message     3SBio Inc.

Upcoming FDA Approval of a small cap company's drug for Anemia patients  The upcoming FDA Decision date on JUNE 29th (Monday) for this small cap company's drug for Anemia patients will affect SSRX directly. To read about HOW it will affect SSRX and about our opinion on whether the drug will be approved or not, along with details of the company, the drug, the disease, the competitors, the market and the sales... more » ritushreeya - Jun 27, 5:48 am - 1 new of 1 message     3SBio Inc.

Upcoming FDA Decision on June 29th on approval of a small cap company's drug for Anemia patients  The upcoming FDA Decision date on JUNE 29th (Monday) for this small cap company's drug for Anemia patients will affect SSRX directly. To read about HOW it will affect SSRX and about our opinion on whether the drug will be approved or not, along with details of the company, the drug, the disease, the competitors, the market and the sales... more » kamalika4321 - Jun 26, 7:52 am - 1 new of 1 message     3SBio Inc.

Upcoming Clinical Trials data of a small cap company's Alzheimer's drug to be presented in July  A small cap company is going to be presenting data on their Alzheimer's drug at the Alzheimer's conference in July. If the trials data is positive, it brings the company one step closer to the approval of a breakthrough treatment for Alzheimer's disease. To find out about the company, the drug, how the drug works, who are the other... more » Debarati - Jun 25, 7:22 am - 1 new of 1 message     3SBio Inc.

Upcoming FDA Panel recommendation on June 26th of a small cap company's Opthalmic (eye) drug.  FDA Panel meeting on Friday (June 26th) to recommend approval on a small cap company's opthalmic drug. If the drug is eventually approved, the Peak Sales of this drug could reach over 100% of the current market cap of the company. To read about the drug, the disease, the market, and how the drug compares to competitors, get a... more » lopamudra - Jun 24, 9:06 am - 1 new of 1 message     3SBio Inc.

Upcoming FDA decision on the approval of a small cap company's Depression drug  The FDA approval decision date for a small cap company's Depression drug is coming up in July. If approved, this could become a breakthrough treatment for Depression and take a sizable bite out of major players like Forest Labs and Wyeth's market share. To find out what the chances are of this new drug being approved, how the drug... more » lopamudra - Jun 22, 9:20 am - 1 new of 1 message     3SBio Inc.

High Volume and down... why?  What is happening with this stock? Seems like it should be on the up and up, but its being very volatile. Any explanations? erede...@gmail.com - Sep 23 2008, 2:27 pm - 1 new of 1 message     3SBio Inc.

Long term strategy  3SBio is selling Amgen and Biogen's drugs to the world's biggest, but not the world's richest market...at least not yet. That makes for very strong promise for the very long term IMHO. China Investment Guidance #1 Newsletter, China Stock Digest New investing guidebook, “Becoming Your Own China Stock Guru” is... more » geowo...@gmail.com - Jun 6 2008, 2:39 pm - 1 new of 1 message     3SBio Inc.

©2009 Google